Market revenue in 2023 | USD 3,880.4 million |
Market revenue in 2030 | USD 4,981.3 million |
Growth rate | 3.6% (CAGR from 2023 to 2030) |
Largest segment | Instruments |
Fastest growing segment | Software |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Services, Software |
Key market players worldwide | Thermo Fisher Scientific Inc, Waters Corp, Shimadzu Corp, Danaher Corp, Agilent Technologies Inc, Bruker Corp, PerkinElmer, Mettler-Toledo International Inc, ZEISS Group, Bio-Rad Laboratories Inc, Illumina Inc, Eppendorf, Roche Holding AG, Sartorius AG, Avantor Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to analytical instrumentation market will help companies and investors design strategic landscapes.
Instruments was the largest segment with a revenue share of 54.13% in 2023. Horizon Databook has segmented the Germany analytical instrumentation market based on instruments, services, software covering the revenue growth of each sub-segment from 2018 to 2030.
Germany accounted for a significant revenue share of Europe analytical instrumentation market owing to the presence of a substantial number of providers offering NGS tools and initiatives undertaken by them to expand the scope of these tools. QIAGEN, CeGaT GmbH, Intrexon Bioinformatics Germany GmbH, and Eurofins Scientific are some of the companies significantly impacting the growth of this region.
For instance, in May 2022, QIAGEN N.V. launched QIAxcel Connect, a nucleic acid analysis capillary electrophoresis instrument. Moreover, technological advancements and innovative product launches are expected to accelerate market expansion.
For instance, in May 2022, Spindiag GmbH received CE marking for two PCR testing systems. These tests are used to diagnose influenza A/B, COVID-19, and RSV. This launch complemented the company’s portfolio in Austria and Germany.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany analytical instrumentation market , including forecasts for subscribers. This country databook contains high-level insights into Germany analytical instrumentation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account